isoproterenol has been researched along with 6-[3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl]-3-(2-methoxyphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auld, DS; Austin, CP; Huang, R; Inglese, J; Leclair, CA; Maguire, W; Michnick, SW; Skoumbourdis, AP; Stefan, E; Thomas, CJ; Titus, SA; Turjanski, AG; Xia, M | 1 |
1 other study(ies) available for isoproterenol and 6-[3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl]-3-(2-methoxyphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
| Article | Year |
|---|---|
Exploration and optimization of substituted triazolothiadiazines and triazolopyridazines as PDE4 inhibitors.
Topics: Binding Sites; Cell Line; Computer Simulation; Cyclic Nucleotide Phosphodiesterases, Type 4; Furans; Humans; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Protein Isoforms; Pyridazines; Structure-Activity Relationship; Thiadiazines; Triazoles | 2009 |